These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 21438632)
1. In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery. Lacombe O; Videau O; Chevillon D; Guyot AC; Contreras C; Blondel S; Nicolas L; Ghettas A; Bénech H; Thevenot E; Pruvost A; Bolze S; Krzaczkowski L; Prévost C; Mabondzo A Mol Pharm; 2011 Jun; 8(3):651-63. PubMed ID: 21438632 [TBL] [Abstract][Full Text] [Related]
2. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869 [TBL] [Abstract][Full Text] [Related]
3. Murine in vitro model of the blood-brain barrier for evaluating drug transport. Shayan G; Choi YS; Shusta EV; Shuler ML; Lee KH Eur J Pharm Sci; 2011 Jan; 42(1-2):148-55. PubMed ID: 21078386 [TBL] [Abstract][Full Text] [Related]
4. In vitro models for the blood-brain barrier. Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540 [TBL] [Abstract][Full Text] [Related]
5. Case study: adapting in vitro blood-brain barrier models for use in early-stage drug discovery. Vandenhaute E; Sevin E; Hallier-Vanuxeem D; Dehouck MP; Cecchelli R Drug Discov Today; 2012 Apr; 17(7-8):285-90. PubMed ID: 22033197 [TBL] [Abstract][Full Text] [Related]
6. Nicotine and cotinine increases the brain penetration of saquinavir in rat. Manda VK; Mittapalli RK; Bohn KA; Adkins CE; Lockman PR J Neurochem; 2010 Dec; 115(6):1495-507. PubMed ID: 20950334 [TBL] [Abstract][Full Text] [Related]
7. How well can in vitro brain microcapillary endothelial cell models predict rodent in vivo blood-brain barrier permeability? Avdeef A Eur J Pharm Sci; 2011 Jun; 43(3):109-24. PubMed ID: 21514381 [TBL] [Abstract][Full Text] [Related]
8. Progress in brain penetration evaluation in drug discovery and development. Liu X; Chen C; Smith BJ J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948 [TBL] [Abstract][Full Text] [Related]
9. In vitro porcine blood-brain barrier model for permeability studies: pCEL-X software pKa(FLUX) method for aqueous boundary layer correction and detailed data analysis. Yusof SR; Avdeef A; Abbott NJ Eur J Pharm Sci; 2014 Dec; 65():98-111. PubMed ID: 25239510 [TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier in vitro models as tools in drug discovery: assessment of the transport ranking of antihistaminic drugs. Neuhaus W; Mandikova J; Pawlowitsch R; Linz B; Bennani-Baiti B; Lauer R; Lachmann B; Noe CR Pharmazie; 2012 May; 67(5):432-9. PubMed ID: 22764578 [TBL] [Abstract][Full Text] [Related]
11. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability. Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068 [TBL] [Abstract][Full Text] [Related]
12. Barrier functionality and transport machineries of human ECV304 cells. Barar J; Gumbleton M; Asadi M; Omidi Y Med Sci Monit; 2010 Jan; 16(1):BR52-60. PubMed ID: 20037486 [TBL] [Abstract][Full Text] [Related]
13. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration. Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020 [TBL] [Abstract][Full Text] [Related]
14. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease. Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978 [TBL] [Abstract][Full Text] [Related]
15. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness. Cohen-Kashi Malina K; Cooper I; Teichberg VI Brain Res; 2009 Aug; 1284():12-21. PubMed ID: 19501061 [TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics. Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782 [TBL] [Abstract][Full Text] [Related]
17. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia? Feng S; Huang Y; Chen Z Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042 [TBL] [Abstract][Full Text] [Related]
18. An in vitro transport model for rapid screening and predicting the permeability of candidate compounds at blood-brain barrier. Yang ZH; Sun X; Mei C; Sun XB; Liu XD; Chang Q J Asian Nat Prod Res; 2011 Dec; 13(12):1087-97. PubMed ID: 22115032 [TBL] [Abstract][Full Text] [Related]
19. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters. Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463 [TBL] [Abstract][Full Text] [Related]